Genmab - ADR
GMAB
Market Cap$13.15B
Close$
$8.53
58.4% downside
Current Fair Value
58.4% downsideOvervalued by 58.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.15 Billion |
|---|---|
| Enterprise Value | $11.91 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $12.14 |
| Beta | 0.82 |
| Outstanding Shares | 637,250,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 13.07 |
|---|---|
| PEG | -15.33 |
| Price to Sales | 0.73 |
| Price to Book Ratio | 2.57 |
| Enterprise Value to Revenue | 0.66 |
| Enterprise Value to EBIT | 1.97 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Genmab
CEO: Jan van de Winkel